Open access
87
Views
21
CrossRef citations to date
0
Altmetric
Original Research
Real-world medication persistence and outcomes associated with basal insulin and glucagon-like peptide 1 receptor agonist free-dose combination therapy in patients with type 2 diabetes in the US
Jay Lin1 Health Economics and Outcomes Research, Novosys Health, Green Brook, NJ, USACorrespondence[email protected]
, Melissa Lingohr-Smith1 Health Economics and Outcomes Research, Novosys Health, Green Brook, NJ, USA
& Tao Fan2 North America Medical Affairs, Sanofi US, Inc., Bridgewater, NJ, USA
Pages 19-29
|
Published online: 22 Dec 2016
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.